Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Best of the Week: Cardiologist pays $6.75M | 3 big recalls hit cardiology | Intermittent fasting & heart disease
Saturday, September 25, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Florida cardiologist pays $6.75M to resolve fraud allegations

The physician and his practice also had to sign into a “multi-year integrity agreement” that includes specific training and reporting requirements.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Florida cardiologist pays $6.75M to resolve fraud allegations

Share on Twitter Share on Facebook Share on Linkedin
The physician and his practice also had to sign into a “multi-year integrity agreement” that includes specific training and reporting requirements.
READ MORE >

Medtronic recalls embolization devices after 2 deaths, 10 serious injuries

Nearly 9,000 devices distributed in 2019 and 2020 are included in this Class 1 recall. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls embolization devices after 2 deaths, 10 serious injuries

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
Nearly 9,000 devices distributed in 2019 and 2020 are included in this Class 1 recall. 
READ MORE >

Best of the best? Meet the world’s top 250 hospitals for cardiology

Fifteen of the list's top 25 hospitals are located in the United States. 

READ MORE >
projected radiation oncology workforce supply and demand
Share on Twitter Share on Facebook Share on Linkedin

Best of the best? Meet the world’s top 250 hospitals for cardiology

Share on Twitter Share on Facebook Share on Linkedin
projected radiation oncology workforce supply and demand
Fifteen of the list's top 25 hospitals are located in the United States. 
READ MORE >

FDA announces recall of 25,000 catheters after 167 complaints, 8 injuries

Parts of the device can move or become loose during procedures, the FDA warned. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of 25,000 catheters after 167 complaints, 8 injuries

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Parts of the device can move or become loose during procedures, the FDA warned. 
READ MORE >

Boston Scientific acquires thrombectomy specialists for $269M

Boston Scientific had already been a strategic investor in Devoro Medical since 2019, holding an equity stake in the company of approximately 16%.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific acquires thrombectomy specialists for $269M

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific had already been a strategic investor in Devoro Medical since 2019, holding an equity stake in the company of approximately 16%.
READ MORE >

New TAVR system for high-risk patients gains FDA approval

The system was specifically designed for patients who should avoid open-heart surgery.  

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

New TAVR system for high-risk patients gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The system was specifically designed for patients who should avoid open-heart surgery.  
READ MORE >

Intermittent fasting may lower risk of heart disease, diabetes

“People who are trying to lose weight and live a healthier lifestyle should pay more attention to when they eat as well as what they eat,” researchers wrote.

READ MORE >
clock
Share on Twitter Share on Facebook Share on Linkedin

Intermittent fasting may lower risk of heart disease, diabetes

Share on Twitter Share on Facebook Share on Linkedin
clock
“People who are trying to lose weight and live a healthier lifestyle should pay more attention to when they eat as well as what they eat,” researchers wrote.
READ MORE >

Additional lots of losartan recalled due to potential cancer risk

Two different companies announced that they are recalling all lots of the medication. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

Additional lots of losartan recalled due to potential cancer risk

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Two different companies announced that they are recalling all lots of the medication. 
READ MORE >

1 in 10 young adults with left-sided breast cancer develop heart disease

The average follow-up period was 14 years, giving any radiation-associated complications time to develop.

READ MORE >
a patient talks with her doctor, both are women of color
Share on Twitter Share on Facebook Share on Linkedin

1 in 10 young adults with left-sided breast cancer develop heart disease

Share on Twitter Share on Facebook Share on Linkedin
a patient talks with her doctor, both are women of color
The average follow-up period was 14 years, giving any radiation-associated complications time to develop.
READ MORE >

Heart rhythm specialists awarded $3M to develop new AFib therapy

“AFib remains a serious arrhythmia, and additional treatment options are needed,” one cardiologist said. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Heart rhythm specialists awarded $3M to develop new AFib therapy

Share on Twitter Share on Facebook Share on Linkedin
“AFib remains a serious arrhythmia, and additional treatment options are needed,” one cardiologist said. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme